Introduction
The autonomic nervous system consists of the sympathetic and parasympathetic divisions. As the name implies, the lumbar sympathetic block can be utilized to disrupt the nerve supply from the sympathetic chain to the lower extremities. This is useful in treating sympathetic mediators of pain. Specifically, lumbar sympathetic blocks can be used for the treatment of painful conditions such as complex regional pain syndrome, phantom limb pain, hyperhidrosis, painful vascular insufficiencies, and pain from herpes zoster/shingles.[1][2]
Anatomy and Physiology
Register For Free And Read The Full Article
- Search engine and full access to all medical articles
- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Anatomy and Physiology
The sympathetic trunk is comprised of a nerve bundle that runs from the skull base to the coccyx. Its main function is to mediate the body's "fight or flight" response, and it also plays an integral role in maintaining homeostasis in conjunction with the parasympathetic nervous system. The lumbar sympathetic trunk is located along the anterolateral aspect of the first through fourth lumbar vertebra. The preganglionic neurons exit the spinal cord via white rami of the ventral roots of spinal nerves L1 to L4 and then synapse at the appropriate lumbar sympathetic ganglion. From there, the postganglionic neurons extend distally and innervate specific sites. The densest portion of lumbar sympathetic ganglia resides in L2 and L3, therefore, lumbar sympathetic blocks are most commonly performed along with the lower third of L2 or the upper third of L3 levels.[3][4]
Indications
According to the practice guidelines for chronic pain management by the American Society of Anesthesiologists, lumbar sympathetic blocks are indicated for the treatment of a multitude of sympathetic-mediated pain disorders.
- Complex regional pain syndrome, formerly referred to as reflex sympathetic dystrophy, is characterized by dysregulation of the central and autonomic nervous system causing unregulated pain and temperature control on the affected extremity.[5] It is most commonly seen in patients who sustain an injury to the soft tissue or peripheral nerves of an extremity. Clinical features include vasomotor dysfunction, swelling, allodynia, and hyperalgesia. Affected limbs are often swollen, edematous, and may display trophic changes of the skin due to aberrant vasomotor activity.[6][7]
- Lower limb painful ischemia - The National Institute for Health and Clinical Excellence states that approximately 20% of the patients with painful ischemia of the lower limbs secondary to vascular disease are not candidates for surgical intervention due to either the pattern of their disease or medical co-morbidities. In these patients, lumbar sympathetic blocks may be utilized to reduce pain, improve wound healing, and potentially delay or avoid limb amputation. In these cases, the lumbar sympathetic block serves to disrupt the sympathetic innervation to the vascular supply of the lower extremity, thus causing vasodilation and subsequently improved blood flow to the limb.[8][9]
- Phantom limb pain - A phenomenon in which pain is perceived from a limb that is no longer present. Although the mechanism is poorly understood, studies report an incidence of phantom limb pain in amputee patients between 42% to 78%. Case studies have found lumbar sympathetic blocks to be safe and effective for the alleviation of phantom limb pain.[10][11][12]
- Neuropathic pain - sustained pain relief in a patient with intractable diabetic neuropathy.[1][13][14]
- Postherpetic neuralgia secondary to zoster. There is improvement in pain, function, and quality of life after lumbar sympathetic block in patients with postherpetic neuralgia secondary to zoster (Shingles).[15][16][17]
- Hyperhidrosis[18][19][20]
- Raynaud disease [21][22]
- Cancer pain[23]
Contraindications
- Anticoagulant therapy that can not be stopped
- Conditions with altered coagulation parameters
- Allergies to any of the medications that are injected
- Uncontrolled diabetes
- Poorly controlled heart disease
- Patient refusal
Equipment
Required equipment includes a mobile fluoroscopic C-arm x-ray. Additionally, the physician will need epidural spinal needles, sterile gloves, medications, contrast, sterile drapes, and betadine solution. Cardiac monitors and pulse oximeters are needed to monitor the patient's vitals.
Personnel
Staff typically consists of a nurse or assistant, a fluoroscopic C-arm operator, and a physician.
Preparation
A time-out should be performed at which time the staff identify the patient, discuss which procedure will be performed, and verify the side of the body to be treated. The patient should be placed on the fluoroscopy table in the prone position. Some clinicians choose to provide the patient with intravenous sedation at this time. Once the target area has been identified, the area should be cleaned thoroughly with a betadine solution and then covered with a sterile draping. After the patient has been positioned appropriately and the skin has been sterilized, the clinician may proceed.
Technique or Treatment
The fluoroscope's C-arm imaging projector should be positioned such that the L2 and L3 vertebrae are easily visualized, and the superior endplates are aligned. Occasionally, the procedure is done under computed tomography guidance. The C-arm is placed in the oblique plane until the end of the transverse process is aligned with the anterior aspect of the vertebral body to avoid the transverse process during the insertion of the needle. The needle should be aimed towards the anterior aspect of the vertebral bodies of L2 or L3.[23] Sometimes, the block is done at both levels. Local anesthesia is injected at the planned entry point. Once the trajectory has been confirmed, the C-arm should be returned to an anteroposterior view. From here, the needle is introduced and advanced. It should approach the target vertebral body in the mid pedicular position. The needle should be in contact with the vertebra and "walked along" the vertebral body to ensure correct placement. The great vessels are located ventral to the vertebral bodies. A lateral image should be obtained to verify the depth of the needle. The needle should be adjusted so that it is three to five millimeters dorsal to the most ventral portion of the vertebral body.
Once in the correct position, and aspiration was negative for air, blood, or cerebrospinal fluid, 1 mL of contrast is injected to ensure adequate flow and proper location. The clinician should be able to visualize the contrast covering the anterior portion of the vertebral body with an inferior and superior spread at L1 to L3. After adequate location and craniocaudal spread, the medication (anesthetic bupivacaine 0.5%, ethanol 96%, or botulinum toxin) is injected to complete the lumbar sympathetic blockade. The needle is removed and pressure is applied on the entry point and then covered with a bandage. The greatest indication of a successful lumbar sympathetic block is a two-three degree Celcius rise in the temperature of the affected limb. The patient might also note that the skin of the extremity on the injected side will become flushed as a result of blood vessel dilation.
Complications
The most common complications include bleeding, bruising, swelling, and soreness at the site of injection. This is usually self-limited and resolves within hours to days of having the procedure. Some patients have also reported dizziness, headache, and transient numbness, and weakness of the leg on the side that was injected.[24][25][26][27] More serious complications include infection, visceral injury, intravascular injection, intralymphatic injection, ureter injury, kidney injury, Horner's syndrome, an allergic reaction to the medication, although these occurrences are exceedingly rare.[28][29][30][31][32][33][34]. Anterior thigh pain, presumably from damage to the genitofemoral nerve and lateral femoral cutaneous nerve, may occur in some patients.[24][35]
Clinical Significance
Overall, the lumbar sympathetic block is a safe and effective procedure that can be used to alleviate pain in the appropriate patient population. This includes people with vascular insufficiency of the lower extremities, complex regional pain syndrome, phantom limb pain, postherpetic neuralgia, and other neuropathic pain syndromes that are refractory to medical management.[36][37]
Enhancing Healthcare Team Outcomes
The nurse and physician performing the procedure must be aware of the most common complications include bleeding, bruising, swelling, and soreness at the site of injection. The agent is usually prepared by the pharmacy; dosing and proper formulation fall to them to perform correctly and discuss any potential adverse effects with the team. The nurse must provide monitoring and report untoward events such as dizziness and transient numbness and weakness of the leg on the side that was injected. More serious complications including infection, intravascular injection, and allergic reaction to the medication may occur and the interprofessional healthcare team should be prepared to work together to respond. [Level 5] The collaboration of the interdisciplinary team helps to ensure good pain-free results and improve outcomes.
References
Abramov R. Lumbar sympathetic treatment in the management of lower limb pain. Current pain and headache reports. 2014 Apr:18(4):403. doi: 10.1007/s11916-014-0403-x. Epub [PubMed PMID: 24643353]
Awal S, Madabushi R, Agarwal A, Singla V. CRPS: Early Lumbar Sympathetic Block is Better Compared to Other Interventions. Pain physician. 2016 Feb:19(2):E363 [PubMed PMID: 26815268]
Feigl GC, Kastner M, Ulz H, Breschan C, Pixner T, Dreu M, Umschaden HW, Likar R. The lumbar sympathetic trunk: its visibility and distance to two anatomical landmarks. Surgical and radiologic anatomy : SRA. 2013 Mar:35(2):99-106. doi: 10.1007/s00276-012-1015-y. Epub 2012 Sep 16 [PubMed PMID: 22983730]
An JW, Koh JC, Sun JM, Park JY, Choi JB, Shin MJ, Lee YW. Clinical Identification of the Vertebral Level at Which the Lumbar Sympathetic Ganglia Aggregate. The Korean journal of pain. 2016 Apr:29(2):103-9. doi: 10.3344/kjp.2016.29.2.103. Epub 2016 Apr 1 [PubMed PMID: 27103965]
van Eijs F, Stanton-Hicks M, Van Zundert J, Faber CG, Lubenow TR, Mekhail N, van Kleef M, Huygen F. Evidence-based interventional pain medicine according to clinical diagnoses. 16. Complex regional pain syndrome. Pain practice : the official journal of World Institute of Pain. 2011 Jan-Feb:11(1):70-87. doi: 10.1111/j.1533-2500.2010.00388.x. Epub 2010 Aug 27 [PubMed PMID: 20807353]
Carroll I, Clark JD, Mackey S. Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Annals of neurology. 2009 Mar:65(3):348-51. doi: 10.1002/ana.21601. Epub [PubMed PMID: 19334078]
Level 3 (low-level) evidenceMeier PM, Zurakowski D, Berde CB, Sethna NF. Lumbar sympathetic blockade in children with complex regional pain syndromes: a double blind placebo-controlled crossover trial. Anesthesiology. 2009 Aug:111(2):372-80. doi: 10.1097/ALN.0b013e3181aaea90. Epub [PubMed PMID: 19602962]
Level 1 (high-level) evidenceBarreto Junior EPS, Nascimento JDS, de Castro APCR. [Neurolitic block of the lumbar sympathetic chain improves chronic pain in a patient with critical lower limb ischemia]. Brazilian journal of anesthesiology (Elsevier). 2018 Jan-Feb:68(1):100-103. doi: 10.1016/j.bjan.2015.03.007. Epub 2016 Jan 23 [PubMed PMID: 26809966]
Manjunath PS, Jayalakshmi TS, Dureja GP, Prevost AT. Management of lower limb complex regional pain syndrome type 1: an evaluation of percutaneous radiofrequency thermal lumbar sympathectomy versus phenol lumbar sympathetic neurolysis--a pilot study. Anesthesia and analgesia. 2008 Feb:106(2):647-9, table of contents. doi: 10.1213/01.ane.0000298285.39480.28. Epub [PubMed PMID: 18227328]
Level 3 (low-level) evidenceMcCormick ZL, Hendrix A, Dayanim D, Clay B, Kirsling A, Harden N. Lumbar Sympathetic Plexus Block as a Treatment for Postamputation Pain: Methodology for a Randomized Controlled Trial. Pain medicine (Malden, Mass.). 2018 Dec 1:19(12):2496-2503. doi: 10.1093/pm/pny041. Epub [PubMed PMID: 29528455]
Level 1 (high-level) evidenceBornemann-Cimenti H, Dorn C, Rumpold-Seitlinger G. Early Onset and Treatment of Phantom Limb Pain Following Surgical Amputation. Pain medicine (Malden, Mass.). 2017 Dec 1:18(12):2510-2512. doi: 10.1093/pm/pnx111. Epub [PubMed PMID: 28475751]
Richardson C, Glenn S, Nurmikko T, Horgan M. Incidence of phantom phenomena including phantom limb pain 6 months after major lower limb amputation in patients with peripheral vascular disease. The Clinical journal of pain. 2006 May:22(4):353-8 [PubMed PMID: 16691088]
Cheng J, Daftari A, Zhou L. Sympathetic blocks provided sustained pain relief in a patient with refractory painful diabetic neuropathy. Case reports in anesthesiology. 2012:2012():285328. doi: 10.1155/2012/285328. Epub 2012 Feb 6 [PubMed PMID: 22606406]
Level 3 (low-level) evidenceMashiah A, Soroker D, Pasik S, Mashiah T. Phenol lumbar sympathetic block in diabetic lower limb ischemia. Journal of cardiovascular risk. 1995 Oct:2(5):467-9 [PubMed PMID: 8749275]
Yamagami H, Hashizume K, Sha K, Furuya H, Okuda T. [Evaluation of selective lumbar radiculography and radicular block]. Masui. The Japanese journal of anesthesiology. 1994 Feb:43(2):253-7 [PubMed PMID: 8164333]
Kageshima K, Wakasugi B, Shiotani M, Ooseto K, Yuda Y, Karasawa H, Ohno K. [Thoracic and lumbar sympathetic ganglion block for post herpetic neuralgia]. Masui. The Japanese journal of anesthesiology. 1992 Jan:41(1):106-10 [PubMed PMID: 1545488]
Level 2 (mid-level) evidenceMalec-Milewska M, Sękowska A, Kolęda I, Horosz B, Guć M, Jastrzębski J. Sympathetic nerve blocks for the management of postherpetic neuralgia - 19 years of pain clinic experience. Anaesthesiology intensive therapy. 2014 Sep-Oct:46(4):255-61. doi: 10.5603/AIT.a2014.0039. Epub [PubMed PMID: 25293476]
Level 2 (mid-level) evidenceKim WO, Yoon KB, Kil HK, Yoon DM. Chemical lumbar sympathetic block in the treatment of plantar hyperhidrosis: a study of 69 patients. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2008 Oct:34(10):1340-5. doi: 10.1111/j.1524-4725.2008.34286.x. Epub 2008 Jun 30 [PubMed PMID: 18616535]
Level 2 (mid-level) evidenceYun SW, Kim YS, Lee Y, Lim HJ, Park SI, Jung JP, Park CR. Outcome of Limited Video-Assisted Lumbar Sympathetic Block for Plantar Hyperhidrosis Using Clipping Method. Journal of laparoendoscopic & advanced surgical techniques. Part A. 2017 Jan:27(1):36-42. doi: 10.1089/lap.2016.0387. Epub 2016 Sep 13 [PubMed PMID: 27622702]
Aşik ZS, Orbey BC, Aşik I. Sympathetic radiofrequency neurolysis for unilateral lumbar hyperhidrosis: a case report. Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology. 2008 Jul:20(3):37-9 [PubMed PMID: 19085180]
Level 3 (low-level) evidenceEllis H. Lumbar sympathectomy. British journal of hospital medicine. 1986 Feb:35(2):124-5 [PubMed PMID: 3730665]
Skeehan TM, Cory PC Jr. Neurolytic lumbar sympathetic block in the treatment of Raynaud's phenomenon. Anesthesiology. 1986 Jan:64(1):119-20 [PubMed PMID: 3942322]
Level 3 (low-level) evidenceSpiegel MA, Hingula L, Chen GH, Legler A, Puttanniah V, Gulati A. The Use of L2 and L3 Lumbar Sympathetic Blockade for Cancer-Related Pain, an Experience and Recommendation in the Oncologic Population. Pain medicine (Malden, Mass.). 2020 Jan 1:21(1):176-184. doi: 10.1093/pm/pnz142. Epub [PubMed PMID: 31274168]
Feigl GC, Dreu M, Ulz H, Breschan C, Maier C, Likar R. Susceptibility of the genitofemoral and lateral femoral cutaneous nerves to complications from lumbar sympathetic blocks: is there a morphological reason? British journal of anaesthesia. 2014 Jun:112(6):1098-104. doi: 10.1093/bja/aet552. Epub 2014 Feb 18 [PubMed PMID: 24554547]
Level 3 (low-level) evidencePennekamp W, Krumova EK, Feigl GP, Frombach E, Nicolas V, Schwarzer A, Maier C. Permanent lesion of the lateral femoral cutaneous nerve after low-volume ethanol 96%application on the lumbar sympathetic chain. Pain physician. 2013 Jul-Aug:16(4):391-7 [PubMed PMID: 23877455]
Level 3 (low-level) evidenceArtuso JD, Stevens RA, Lineberry PJ. Post dural puncture headache after lumbar sympathetic block: a report of two cases. Regional anesthesia. 1991 Sep-Oct:16(5):288-91 [PubMed PMID: 1958610]
Level 3 (low-level) evidenceJoshi SM, Hehre FW. Peridural block complicating lumbar sympathetic block. Anesthesia and analgesia. 1977 Nov-Dec:56(6):873-4 [PubMed PMID: 22274]
Level 3 (low-level) evidenceDirim A, Kumsar S. Iatrogenic ureteral injury due to lumbar sympathetic block. Scandinavian journal of urology and nephrology. 2008:42(5):492-3. doi: 10.1080/00365590802045038. Epub [PubMed PMID: 18609289]
Level 2 (mid-level) evidenceWheatley JK, Motamedi F, Hammonds WD. Page kidney resulting from massive subcapsular hematoma. Complication of lumbar sympathetic nerve block. Urology. 1984 Oct:24(4):361-3 [PubMed PMID: 6485196]
Level 3 (low-level) evidenceHaynsworth RF Jr, Noe CE, Fassy LR. Intralymphatic injection: another complication of lumbar sympathetic block. Anesthesiology. 1994 Feb:80(2):460-2 [PubMed PMID: 8311326]
Level 3 (low-level) evidenceEGBERT LD. Horner's syndrome; complication of lumbar sympathetic block. Anesthesiology. 1955 Sep:16(5):811-2 [PubMed PMID: 13249119]
Maranhão-Filho PA, Martins MA, Lopes HF. Horner's syndrome and brachial paresis as a complication of lumbar sympathetic block: a case report. Arquivos de neuro-psiquiatria. 1995 Dec:53(4):831-3 [PubMed PMID: 8729783]
Level 3 (low-level) evidenceSAMUELSSON SM, HOEGSTR-OM S. [RETROPERITONEAL HEMATOMA FOLLOWING LUMBAR SYMPATHETIC NERVE BLOCK]. Svenska lakartidningen. 1964 Sep 30:61():2894-903 [PubMed PMID: 14222119]
Lönnqvist PA, MacKenzie J, Soni AK, Conacher ID. Paravertebral blockade. Failure rate and complications. Anaesthesia. 1995 Sep:50(9):813-5 [PubMed PMID: 7573876]
Level 3 (low-level) evidenceSayson SC, Ramamurthy S, Hoffman J. Incidence of genitofemoral nerve block during lumbar sympathetic block: comparison of two lumbar injection sites. Regional anesthesia. 1997 Nov-Dec:22(6):569-74 [PubMed PMID: 9425975]
Level 1 (high-level) evidenceGovedarski V, Petrov I, Zahariev T, Nachev G. [Adjuvant and individual application of lumbar sympathectomy at patient with arterial disease in lower limb]. Khirurgiia. 2010:(1):19-23 [PubMed PMID: 21972699]
Dworkin RH, O'Connor AB, Kent J, Mackey SC, Raja SN, Stacey BR, Levy RM, Backonja M, Baron R, Harke H, Loeser JD, Treede RD, Turk DC, Wells CD. Interventional management of neuropathic pain: NeuPSIG recommendations. Pain. 2013 Nov:154(11):2249-2261. doi: 10.1016/j.pain.2013.06.004. Epub 2013 Jun 6 [PubMed PMID: 23748119]
Level 1 (high-level) evidence